Eton Pharmaceuticals focuses on developing and commercializing therapies for patients with rare diseases, leveraging a diversified pipeline of product candidates. The company emphasizes its ability to identify and accelerate the commercialization of promising products that are already in development, allowing for rapid market entry. Eton's business model is built on forming strategic partnerships with development collaborators across the United States and Europe, which enhances their capacity to bring multiple therapies to market efficiently. This collaborative approach enables Eton to maintain a robust pipeline, with several products undergoing FDA review at any given time.

The company is committed to making a significant impact on underserved populations by providing innovative treatments for rare conditions. Eton's leadership highlights their agility and proven execution capabilities, from conducting clinical trials to achieving successful commercialization. By focusing on therapies that address the needs of small patient populations, Eton Pharmaceuticals aims to offer real hope and meaningful solutions, ultimately striving to change lives through their dedicated efforts in the pharmaceutical landscape.

United States

Eton Pharmaceuticals, Inc. is a Deer Park, Illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the U.S. Food and Drug Administration’s 505(b)(2) regulatory pathway. Our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.

Endocrine System Diseases

Metabolic Diseases

Eton Pharmaceuticals

Hyperammonemia

Carbaglu® (carglumic acid tablets)

Allergy

Eye disease

Alaway® Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye drops (EM-100)

Hypotension

Phenylephrine hydrochloride is an α-1 adrenergic receptor agonist.

Biorphen® (phenylephrine HCI)

Migraines

Neurological disorder

Seizures

EPRONTIA (Topiramate Oral Solution) (ET-101)

Rezipres (Ephedrine Injection) (ET-203)

Nutritional requirements of newborn infants

Cysteine hydrochloride injection (generic - ANDA)

Rare genetic disease

ZONISADE (Zonisamide) (ET-104)

ALKINDI® SPRINKLE (hydrocortisone)

Adrenal Insufficiency

ET-400 (Hydrocortisone Oral Solution)

KHINDIVI™ (hydrocortisone) Oral Solution

Rare diseases

Tyrosinemia type 1

Nitisinone Capsules

Diabetes insipidus

ET-600

Methanol poisoning

Dehydrated alcohol is hypobaric in relation to the cerebrospinal fluid. It is injected proximate to nerve tissues and into spinal subarachnoid spaces to produce degeneration of nerve function (neurolysis) for control of chronic pain. <a href="https://www.drugs.com/pro/dehydrated-alcohol-injection.html#:~:text=Dehydrated%20alcohol%20is%20hypobaric%20in,for%20control%20of%20chronic%20pain.">source</a>

Eton Pharmaceuticals

Company Details